Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
The association of primary biliary cirrhosis (PBC) and autoimmune hepatitis (AIH) is thought to be rare, and its optimal treatment is unknown. Of 130 consecutive patients with a diagnosis of PBC, we identified 12 cases (9.2%) of overlap syndrome (10 females, 2 males; median age, 50 years) strictly defined by the presence of at least two of the three recognized biochemical, serological, and histological criteria of each disease. One patient had initially pure PBC and developed AIH characterized by a flare of alanine transaminase (ALT) (1,330 IU/L; N < 35), elevated immunoglobulin G (IgG) (42 g/L; N < 14.0), and presence of anti-smooth muscle antibodies (ASMA) after 20 months of ursodeoxycholic acid (UDCA) therapy. A complete clinical and biochemical remission was achieved under combination of corticosteroids and UDCA. Eleven patients had features of both diseases at presentation: high serum levels of alkaline phosphatase (AP) (median: 280 IU/L; N < 100), ALT (140 IU/L), and IgG (30.8 g/L), presence of mitochondrial antibodies (n = 9) or ASMA (n = 9), florid bile duct lesions (n = 8), and moderate or severe periportal or periseptal lymphocytic piecemeal necrosis (n = 11). UDCA (13-15 mg/kg/d) given alone in 5 patients induced a significant decrease in biochemical cholestasis but not in ALT levels, and liver fibrosis progressed in 3 patients. Corticosteroids given alone in 6 patients induced a significant decrease in ALT, IgG, and AP levels, but none had a biochemical normalization. The patients with persistently abnormal liver tests under either UDCA or corticosteroids received both UDCA and corticosteroids. A further marked biochemical improvement was observed, and all patients became asymptomatic. We conclude that, in patients with PBC: 1) overlap syndrome with AIH is not rare; 2) flares of AIH may occur either spontaneously or under UDCA; and 3) combination of UDCA and corticosteroids is required in most patients to obtain a complete biochemical response. Overlap syndrome may represent an important and unrecognized cause of resistance to UDCA in patients with PBC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The available data suggest that patients who fulfil the Paris criteria for the diagnosis of AIH either at presentation or during the course of their PBC may benefit from additional immunosuppression in the short-and medium-term [160,162,175,176].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [162]
In the citing paper
“A simplified AIH scoring system has more recently been developed, and, when applied to PBC patients, it identified fewer patients meeting probable AIH criteria than the older scoring system did (4% versus 12%).(125)(126)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [126]
In the citing paper
“Criteria have been proposed by the Paris group for ‘true’ PBC/AIH overlap,272 with two out of three of (a) ALT >5 x ULN, (b) IgG >2 x ULN or positive anti-SMA and (c) liver biopsy with ‘moderate or severe periportal or periseptal lymphocytic piecemeal necrosis (interface hepatitis)’ being suggested as diagnostic of overlap in the context of a PBC diagnosis.”
From The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines (2018) · cites this paper as [272]
Citations
Cites
An Algorithm for the Grading of Activity in Chronic Hepatitis C
Bedossa, P., & Poynard, T. (1996) · Hepatology · doi:10.1002/hep.510240201 · Cited by 4,088
Bedossa, P. (1994) · Hepatology · doi:10.1002/hep.1840200104 · Cited by 2,003
Kaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 1,959
Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
Ludwig, J., Dickson, E. R., & McDonald, G. S. A. (1978) · Virchows Archiv A Pathological Anatomy and Histology · doi:10.1007/bf00432479 · Cited by 753
Ursodiol for the Long-Term Treatment of Primary Biliary Cirrhosis
Poupon, R. E., Poupon, R., & Balkau, B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405123301903 · Cited by 497
Self-citationUrsodeoxycholic acid in the treatment of primary biliary cirrhosis
Lindor, K. D., Dickson, E. R., Baldus, W. P., Jorgensen, R. A., Ludwig, J., Murtaugh, P. A., Harrison, J. M., Wiesner, R. H., Anderson, M. L., Lange, S. M., et al. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90021-3 · Cited by 487
Kaplan, M. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611213352107 · Cited by 455
Calmus, Y., Gane, P., Rouger, P., & Poupon, R. (1990) · Hepatology · doi:10.1002/hep.1840110104 · Cited by 303
Self-citationInvernizzi, P., Crosignani, A., Battezzati, P. M., Covini, G., De Valle, G., Larghi, A., Zuin, M., & Podda, M. (1997) · Hepatology · doi:10.1002/hep.510250507 · Cited by 293
Michieletti, P., Wanless, I. R., Katz, A., Scheuer, P. J., Yeaman, S. J., Bassendine, M. F., Palmer, J. M., & Heathcote, E. J. (1994) · Gut · doi:10.1136/gut.35.2.260 · Cited by 236
Research works printed but not linked: 2
- Shouval, 1979, Chronic active hepatitis with cholestatic features, Am J Gastroenterol, 72, 542
- Nakamura, 1995, Effect of ursodeoxycholic acid (UDCA) on patients with type 1 auto-immune hepatitis [Abstract], Gastroenterology, 107, 958A
Cited by
Items 601–700 of 743
Acute Liver Failure During Early Pregnancy—Case Report and Review of Literature
Banach, P., Kuczkowska, J., Areshchanka, Y., Banach, W., Rzepka, J. K., Kudliński, B., & Rzepka, R. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14062028 · Cited by 1
福西新弥, 依藤, 直., Yokohama, K., 大濱日出子, Sujishi, T., 土本雄亮, 朝井章, 津田泰宏, Takeshita, A., 和宏, 山., et al. (2013) · Kanzo · doi:10.2957/kanzo.54.705 · Cited by 1
Dohmen, K., 博文, 田., Haruno, M., Aishima, S.-I., & Shimoda, S. (2010) · Kanzo · doi:10.2957/kanzo.51.513 · Cited by 1
Pathology of the Intrahepatic and Extrahepatic Bile Ducts and Gallbladder
Washington, K. M. (2006) · Wiley eBooks · doi:10.1002/9780470986981.ch2 · Cited by 1
Histopathologic Approach to Cholestatic Diseases of the Liver
Jessurun, J. (2018) · AJSP Review and Reports · doi:10.1097/pcr.0000000000000268 · Cited by 2
Enfermedades hep?ticas de patogenia inmunol?gica
Ramrez, J. F. L., Ramrez-Crdenas, D. M., & Murillo, M. P. C. (2004) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(04)70073-9 · Cited by 1
Síndrome "overlap" hepatitis autoinmune-cirrosis biliar primaria: Aportación de dos nuevos casos
Fernández, F. J. F., Aguado, J. D. L. F., Fernández, S. P., Pérez-Argüelles, B. S., Germiñas, A. N., & Vila, M. (2005) · Anales de Medicina Interna · doi:10.4321/s0212-71992005000300008 · Cited by 3
Therapie der Autoimmunhepatitis
Rambusch, E. G., & Manns, M. P. (1999) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/bf03044849 · Cited by 1
“It is characterized by the coexistence of clinical, biochemical or serological features of autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), primary sclerosing Cholangitis (PSC), and depending on the definition also viral hepatitis C [65–70].”
BackgroundAnswers to Multiple Choice Questions
Agrawal, S., & Dhiman, R. K. (2012) · Journal of Clinical and Experimental Hepatology · doi:10.1016/s0973-6883(12)60115-7 · Cited by 1
Defendenti, C., Bollani, S., Munegato, G., Saibeni, S., Sofia, M., Bruno, S., Saudelli, M., & Picca, M. (2008) · Microbiologia medica · doi:10.4081/mm.2008.2580 · Cited by 2
“Seguono gli autoanticorpi SSARo52 e gli anticentromero che, specie se presenti contemporaneamente, danno un franco overlap AIH/PBC.”
BackgroundInfluentialDrug therapy of primary biliary diseases: classical and modern strategies
Schlichting, J., & Leuschner, U. (2001) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2001.tb00144.x · Cited by 1
Conduite à tenir devant une cytolyse chronique
Guyader, D., & Lainé, F. (2003) · EMC - Hépatologie · doi:10.1016/s1155-1976(03)00066-4 · Cited by 1
Autoimmune Hepatitis and Overlap Syndromes
Bantel, H., & Manns, M. P. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-3258-8.50045-0 · Cited by 1
Czaja, A. J. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00088-3 · Cited by 1
Reply to: “Challenges in the diagnosis and management of AIH-PBC syndrome”
Stoelinga, A., Tushuizen, M. E., & van Hoek, B. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101248 · Cited by 1
“3,4 Despite their high speci-fi city, the high cut-offs for both aminotransferases and IgG may underestimate the prevalence of the syndrome, i.e. exclude patients with milder presentations of either AIH, PBC or both disease entities.”
Management of the Patients with Feature of Autoimmune Hepatitis
Abe, K., Takahashi, A., & Ohira, H. (2014) · Springer eBooks · doi:10.1007/978-4-431-54789-1_20
11 Auto-immuunhepatitis en overlapsyndromen
van Hoek, B., van Nieuwkerk, C. M. J., & Jarbandhan, S. V. (2009) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-7437-3_11
Autoimmune Lebererkrankungen und deren Überlappungssyndrome
Teufel, A., & Kanzler, S. (2015) · Die Gastroenterologie · doi:10.1007/s11377-014-0977-1
“Zusammenfassend wird für diese Kriterien eine Sensitivität von 92% und eine Spezifität von 97% berichtet [35].”
BackgroundDancygier, H. (2009) · Springer eBooks · doi:10.1007/978-3-642-04519-6_23
Orphan drugs in development for primary biliary cirrhosis: challenges and progress
Lindor, K. D., Ali, A. H., & Byrne, T. (2015) · Orphan Drugs Research and Reviews · doi:10.2147/odrr.s69477
Cholestatische Lebererkrankungen und Stoffwechselerkrankungen der Leber
Beuers, U. H. (2006) · Springer eBooks · doi:10.1007/3-540-26504-x_46
Advances in classification, prognostication and treatment of immunocholangitis
Vleggaar, F. P. (2000) · EUR Research Repository (Erasmus University Rotterdam)
Epidemiology and Treatment Options of Primary Biliary Cirrhosis
Rautiainen, H. (2008) · Helda - University of Helsinki Institutional Repository
Overlap Syndrome and Connective Tissue Diseases
Heurgué–Berlot, A., Bresson‐Hadni, S., Bernard‐Chabert, B., & Thiéfin, G. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1463-3
Autoimmune hepatitis in a teenage boy: ‘overlap’ or ‘outlier’ syndrome—dilemma for internists
Talukdar, A., Khanra, D., Mukherjee, K., & Saha, M. (2013) · BMJ Case Reports · doi:10.1136/bcr-2012-008335
“Our case ful fi ls the criteria for the diagnosis of AIH-PBC overlap syndrome provided by Chazouilleres et al 16 which is also adopted by the European Association for the Study of the Liver (EASL).”
Biologie des maladies cholestatiques chroniques de l’adulte
Lemoinne, S., & Chazouillères, O. (2017) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(17)30077-1
Self-citationHépatites auto-immunes de l’adulte. Expérience d’un service de médecine interne algérien
Lahcene, M., Oumnia, N., Chiali, N., & Benzaghou, L. (2013) · Journal Africain d Hépato-Gastroentérologie · doi:10.1007/s12157-013-0497-5
Autoimmune liver diseases: internist’s guide from bench to bedside
Visconti, M. (2015) · Italian Journal of Medicine · doi:10.4081/itjm.2015.508
Corpechot, C., & Chazouillères, O. (2011) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(11)54645-9
Self-citationFujiwara, K., Seza, K., Fukuda, Y., Nakano, M., & Yokosuka, O. (2013) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-013-0423-9
Muratori, P. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.608
“Furthermore, during the last few months we observed other three cases of PBCsAIH OS, two of which had a concomitant seropositivity for both antimitochondrial antibodies (AMAs) and anti-dsDNA; both cases were women, 51 and 49 years old, respectively, and both fulfilled Chazouilleres's criteria (”
Is the new diagnostic scoring system of Zeniya and colleagues useful for autoimmune liver diseases?
Horiike, N., & Onji, M. (2005) · Journal of Gastroenterology · doi:10.1007/s00535-005-1718-5
Autoimmune hepatitis and overlap syndromes
Kriese, S., & Heneghan, M. A. (2015) · Medicine · doi:10.1016/j.mpmed.2015.08.005
Clinical Analysis of 75 Patients with Primary Biliary Cirrhosis
Dukova, D. (2014) · Journal of Liver · doi:10.4172/2167-0889.1000161
“These criteria require two of three features associated with AIH and two of three features associated with PBC [6].”
BackgroundSJOGREN SENDROMLU SiR OToiMMUN HEPATiT
Sunumu, O., Yal, K., & Dani, R. (2000)
Rym, E. N. E. (2014) · Journal of Liver · doi:10.4172/2167-0889.1000160
“In addition, the Chazouilllères score, defined by the presence of at least two of the three recognized biochemical, serological, and histological criteria of each disease AIH and PBC, supports the diagnosis of overlap [5].”
BackgroundKatsushima, F., Takahashi, A., Suzuki, T., Ejiri, Y., Abe, K., & Ohira, H. (2013) · FUKUSHIMA JOURNAL OF MEDICAL SCIENCE · doi:10.5387/fms.59.63 · Cited by 1
Chazouillères, O. (2009) · Gastroentérologie Clinique et Biologique · doi:10.1016/j.gcb.2009.07.015
Self-citationAutoimmune cholangitis - a clinical case
Cardoso, A., & Gonçalves, C. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Autoimmune cholangiopathy with dacryocystitis.
Haghazali, S., & Haj-Manouchehry, F. (2009) · PubMed
Ist die Diagnose einer autoimmunen Hepatitis nur durch eine zusätzliche Leberbiopsie möglich?
Strassburg, C. P. (2013) · Die Gastroenterologie · doi:10.1007/s11377-013-0790-2
Managing the Patient with Features of Overlapping Autoimmune Liver Disease
Boberg, K. M. (2011) · Springer eBooks · doi:10.1007/978-1-60761-569-9_12
Boonstra, K. (2014) · UvA-DARE (University of Amsterdam)
Maladies auto-immunes des voies biliaires
Chazouillères, O. (2001) · Gastroentérologie Clinique et Biologique
Self-citationRaykhel`son, K. L., Karev, V. E., Марченко, Н. В., Pal`gova, L. K., Lobzin, Y. V., & Baranovskiy, A. Y. (2014) · Journal Infectology · doi:10.22625/2072-6732-2013-5-4-14-19
La cirrhose biliaire primitive : actualités
Corpechot, C. (2013)
Johanet, C., & Ballot, E. (2010) · EMC - Hépatologie · doi:10.1016/s1155-1976(10)50168-2
Tomizawa, M., Shinozaki, F., Fugo, K., Motoyoshi, Y., Sugiyama, T., Yamamoto, S., Kishimoto, T., & Sueishi, M. (2014) · Kanzo · doi:10.2957/kanzo.55.360
Chen, L., Fan, Z., Peng, Y., & Qiu, D. (2011) · Academic Journal of Second Military Medical University · doi:10.3724/sp.j.1008.2011.00830
A case of polymyositis concomitant with primary biliary cirrhosis simultaneously
Yokosuka, J., Ishikawa, T., Nakao, Y., Saruta, M., Hokari, A., Koike, K., Kitahara, T., Harada, T., Hano, H., & Tajiri, H. (2012) · Kanzo · doi:10.2957/kanzo.53.216
Features, prognosis and management of primary biliary cirrhosis in the era of ursodeoxycholic acid
Poupon, R. Y., Chazouillères, O., Chrétien, Y., & Corpechot, C. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9644-0_37
Self-citationReynolds, J. A., & Carey, E. J. (2016) · Wiley eBooks · doi:10.1002/9781119127437.ch81
A case of PBC-AIH overlap syndrome with systemic sclerosis and liver scar
Yamashita, N., Miyagi, Y., Shimoda, S., Hori, F., Tanimoto, H., Ichiki, Y., Yamamoto, H., & Nomura, H. (2016) · Kanzo · doi:10.2957/kanzo.57.487
Autoimmune Hepatitis and Crossover Syndromes
Janmohamed, A., & Hirschfield, G. M. (2016) · In clinical practice · doi:10.1007/978-3-319-43126-0_12
Autoimmune Liver Diseases: Primary Biliary Cholangitis
Ali, A. H., Carey, E. J., & Lindor, K. D. (2016) · Springer eBooks · doi:10.1007/978-3-319-30103-7_16
Autoimmune Liver Diseases: Overlap Syndromes
Czaja, A. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-30103-7_18
Serological tests for primary biliary cholangitis
Aralica, M., Giljača, V., Poropat, G., Hauser, G., & Štimac, D. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012560
Autoimmune hepatitis : life, death and in-between
Borssén, Å. D. (2017)
Carey, E. J., & Levy, C. (2018) · Clinics in Liver Disease · doi:10.1016/s1089-3261(18)30044-8 · Cited by 1
Fontanella, A., Nardi, R., Masina, M., & Uomo, G. (2017) · Italian Journal of Medicine · doi:10.4081/itjm.q.2017.7
Overlap Syndrome of Autoimmune Hepatitis and Primary Biliary Cirrhosis: A Clinical Enigma
Kumar, S. (2018) · Journal of Advanced Research in Medicine · doi:10.24321/2349.7181.201705
Jones, D. E. (2018) · Wiley eBooks · doi:10.1002/9781119237662.ch17 · Cited by 1
Autoimmune Erkrankungen der Leber
Beuers, U. H. (2006) · Elsevier eBooks · doi:10.1016/b978-343724160-4.50010-5
Fan, X., Wang, H., Shen, M., & Yang, L. (2019) · Annals of Hepatology · doi:10.1016/j.aohep.2019.06.004
Zeniya, M., Iwai, M., & Suriawinata, A. A. (2019) · Springer eBooks · doi:10.1007/978-981-13-6806-6_9
3195 Autoimmune Hepatitis With Primary Biliary Cirrhosis: An Overlapping Syndrome of the Liver
Jobanputra, H., & Shrimanker, I. (2019) · The American Journal of Gastroenterology · doi:10.14309/01.ajg.0000602312.23872.a0
Diseases of the Liver: Primary Biliary Cholangitis
Phillips, P. K., & Said, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-25626-5_7
Making Sense of Overlap and Crossover Syndromes
Chazouillères, O. (2020) · Wiley eBooks · doi:10.1002/9781119532637.ch15
Self-citationTakakusagi, S., Takagi, H., Yokoyama, Y., Marubashi, K., Kizawa, K., Kosone, T., Sato, K., Kakizaki, S., & Uraoka, T. (2020) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-020-01103-w
Heathcote, E. J. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-3258-8.50048-6
Hirschfield, G. M., & Heathcote, E. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00043-7
Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis
Ahn, D. (2020) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2020.75.5.246 · Cited by 2
SÍNDROME DE SOBREPOSICIÓN ENTRE HEPATITIS AUTOINMUNE Y COLANGITIS BILIAR PRIMARIA
Villalba, H. H., Alvarado, A. H., Tinoco, F. D. J. C., Franco, J. A., Serrano, R. Y. M., & Granadillo, M. M. (2020) · Revista Biociencias · doi:10.18041/2390-0512/biociencias.1.6366
“Teniendo en cuenta los criterios de parís (4) para el diagnóstico de HAI/CBP, la paciente cumplió con los tres criterios para el diagnóstico de HAI: ALT elevada >5xLSN, ASMA positivos y biopsia hepática con infiltrado inflamatorio mononuclear portal y daño focal de la placa limitante, sin embargo, los niveles de IgG n…”
BackgroundPrimary Biliary Cholangitis: Autoimmune Hepatitis Overlap Syndrome
Cazzagon, N., & Chazouillères, O. (2020) · Springer eBooks · doi:10.1007/978-3-030-51709-0_24
Self-citationLe syndrome de chevauchement - Cholangite biliaire primitive/hépatite auto-immune
Hanslik, B. (2019) · HEGEL - HEpato-GastroEntérologie Libérale · doi:10.3917/heg.094.0358
Sasaki, Y., Ueno, M., Notohara, K., Sue, M., Kayahara, T., Takabatake, H., Morimoto, Y., Yamamoto, H., & Mizuno, M. (2020) · Kanzo · doi:10.2957/kanzo.61.543
Case Report: Acute presentation of autoimmune hepatitis in a male patient
Hammami, A., Abdessalem, K. B., Mestiri, S., Elleuch, N., Dahmani, W., Ameur, W. B., Ksiaa, M., Slama, A. B., Ajmi, S., Braham, A., et al. (2021) · F1000Research · doi:10.12688/f1000research.52027.1
Marín, J. D. M., Riveros, S. C. H., & Garzón-Olarte, M. (2021) · Hepatología · doi:10.52784/27112330.140 · Cited by 2
Ayar, Ş. N., Aytekin, E. S., Şimşek, C., Cağdaş, D. N., & Balaban, Y. H. (2021) · Research Square · doi:10.21203/rs.3.rs-748416/v1
Juegos para aprender capitalismo
Toral, J. L. C. (2010) · Dialnet (Universidad de la Rioja)
Diagnostic Criteria for Autoimmune Hepatitis : Historical Review and Present Problems
Zeniya, M., & Takahashi, H. (2011) · The Academic Repository of The Jikei University School of Medicine (Jikei University School of Medicine)
Dancygier, H. (2003) · Springer eBooks · doi:10.1007/978-3-642-55902-0_25
Cholangitis and cholangiodysplasia
(2006) · Springer eBooks · doi:10.1007/3-540-28977-1_32
Intrahepatische Gallenwegserkrankungen
Evert, M. (2020) · Pathologie · doi:10.1007/978-3-642-04557-8_9
Czaja, A. J. (2004) · doi:10.1007/978-1-4615-6502-4_3
Kuntz, E., & Kuntz, H.-D. (2002) · Springer eBooks · doi:10.1007/978-3-662-04680-7_32
Wu, Q., Zhao, C. W., & Dai, S. (2022) · Neurology · doi:10.1212/wnl.0000000000200733
“Unauthorized reproduction of this article is prohibited References: [1] Chazouillères O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R.”
BackgroundCholestatische Lebererkrankungen und Stoffwechselerkrankungen der Leber
Beuers, U. H. (2003) · Springer eBooks · doi:10.1007/978-3-662-10475-0_46
Joshi, S., & Heathcote, J. (2002) · Hepatology · doi:10.1053/jhep.2002.36224
Autoimmune hepatitis and overlap syndromes
Bantel, H., Rifai, K., & Manns, M. P. (2012) · Wiley eBooks · doi:10.1002/9781118321386.ch87
Terracciano, L., & Schlageter, M. (2020) · Pathologie · doi:10.1007/978-3-642-04557-8_8
Diagnosis of primary biliary liver diseases, overlap syndromes and changing diagnoses
Heathcote, J. (2007) · Springer eBooks · doi:10.1007/1-4020-2914-4_16
Postgraduate Course: Integrating Basic Science into Clinical Practice
Jo, J., & Thimme, R. (2010) · Hepatology International · doi:10.1007/s12072-010-9173-7
Bruguera, M. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-285-8_54
Answers to Multiple Choice Questions
Agrawal, S., & Dhiman, R. K. (2012) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2012.10.007
Mamari, S. A., Chapman, R. W., & Boberg, K. M. (2013) · Springer eBooks · doi:10.1007/978-3-319-02096-9_21
Beuers, U. H. (2007) · Wiley eBooks · doi:10.1002/9780470691861.ch11e
Heathcote, E. J. (2011) · Springer eBooks · doi:10.1007/978-1-60761-569-9_3
Matsuzaki, Y., Fujimoto, H., Adachi, S., Matsumoto, K., Oyama, S., Saito, H., Saijo, Y., Azuhata, K., Ito, N., Igarashi, T., et al. (2022) · Kanzo · doi:10.2957/kanzo.63.246
Metadata
- Authors
- Chazouillères, O., Wendum, D., Serfaty, L., Montembault, S., Rosmorduc, O., & Poupon, R.
- Affiliations
- Assistance Publique – Hôpitaux de Paris (FR)
- Corresponding author
- Chazouillères, Olivier
- Venue
- Hepatology
- Published
- 1998-08
- Volume
- 28
- Issue
- 2
- Pages
- 296-301
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2056147648
- Semantic Scholar
- e5878dda2aeaf614ad753e5c66ea3a752edfb605
- Cited by
- 746
- References
- 34
- Citations by year
- 2026: 21 · 2025: 29 · 2024: 37 · 2023: 37 · 2022: 32 · 2021: 31 · 2020: 31 · 2019: 27 · 2018: 38 · 2017: 31 · 2016: 28 · 2015: 36 · 2014: 32 · 2013: 32 · 2012: 33
- FWCI
- 12.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 6240 d)
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Keywords
- primary biliary cirrhosis, autoimmune hepatitis, overlap syndrome, ursodeoxycholic acid, corticosteroids, combination therapy, treatment resistance, anti-smooth muscle antibodies, antimitochondrial antibodies, cholestasis, liver fibrosis, IgG, anti-amyloid antibodies, remission, disease flares, bile duct lesions
- MeSH terms
- Adrenal Cortex Hormones, Adult, Aged, Cholagogues and Choleretics, Drug Therapy, Combination, Female, Humans, Immunosuppressive Agents, Liver Cirrhosis, Biliary, Male, Middle Aged, Syndrome, Ursodeoxycholic Acid, Treatment Outcome, Hepatitis, Autoimmune
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.